"plasma cell hepatitis" in liver allografts: Identification and characterization of an IgG4-rich cohort

American Journal of Transplantation

Volumn 13, Issue 11, 2013, Pages 2966-2977

  Castillo Rama, M ^a,b   Sebagh, M ^c   Sasatomi, E ^a,b   Randhawa, P ^a   Isse, K ^a,b   Salgarkar, A D ^a   Ruppert, K ^d   Humar, A ^a   Demetris, A J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c HÔPITAL PAUL BROUSSE   (France)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Fibrosis; IgG4; plasma cell hepatitis; steroid responsiveness

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; CD4 ANTIGEN; HLA DR15 ANTIGEN; IMMUNOGLOBULIN G4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ALLOIMMUNITY; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GENDER; GRAFT RECIPIENT; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; LIVER FIBROSIS; LIVER GRAFT; MALE; PHENOTYPE; PLASMA CELL; PLASMA CELL HEPATITIS; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; SEROLOGY;

FIBROSIS; IGG4; PLASMA CELL HEPATITIS; STEROID-RESPONSIVENESS;

ADULT; AGED; AGED, 80 AND OVER; ALLOGRAFTS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA CELLS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84886803968     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12413     Document Type: Article

References (52)

1. Demetris AJ, Sebagh M., Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis ? Liver Transpl 2008; 14: 750-755. Epub 2008/05/30.
2. Charney DA, Nadasdy T, Lo AW, Racusen LC., Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 68: 791-797. Epub 1999/10/09.
3. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351: 409-413.
4. Heneghan MA, Portmann BC, Norris SM, et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001; 34: 464-470.
5. Guido M, Burra P., De novo autoimmune hepatitis after liver transplantation. Semin Liver Dis 2011; 31: 71-81. Epub 2011/02/24.
6. Banff Working G, Demetris AJ, Adeyi O, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501.
7. Fiel MI, Agarwal K, Stanca C, et al. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008; 14: 861-871. Epub 2008/05/30.
8. Demetris AJ, Eghtesad B, Marcos A, et al. Recurrent hepatitis C in liver allografts: Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004; 28: 658-669. Epub 2004/04/24.
9. Berardi S, Lodato F, Gramenzi A, et al. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: Possible de novo autoimmune hepatitis ? Gut 2007; 56: 237-242. Epub 2006/06/27.
10. Verhagen J, Blaser K, Akdis CA, Akdis M., Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more. Immunol Allergy Clin North Am 2006; 26: 207-231. vi. Epub 2006/05/17.
11. Harada K, Shimoda S, Kimura Y, et al. Significance of IgG4-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 2012; 56: 157-164. Epub 2012/02/01.
12. Adjobimey T, Hoerauf A., Induction of immunoglobulin G4 in human filariasis: An indicator of immunoregulation. Ann Trop Med Parasitol 2010; 104: 455-464. Epub 2010/09/25.
13. Fujita H, Soyka MB, Akdis M, Akdis CA., Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy 2012; 2: 1-8. Epub 2012/03/14.
14. Nirula A, Glaser SM, Kalled SL, Taylor FR., What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011; 23: 119-124. Epub 2010/12/03.
15. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 1538-1546. Epub 2007/05/24.
16. Eguchi S, Takatsuki M, Hidaka M, et al. De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease. J Gastroenterol Hepatol 2008; 23: e165-e169. Epub 2008/05/29.
17. Sebagh M, Coilly A, Castillo-Rama M, Santos AD, et al. Centrilobular changes are key histological findings for segregating cases of de novo autoimmune hepatitis after liver transplantation. J Hepatol 2012; 56: S381-S382.
18. Isse K, Grama K, Abbott IM, et al. Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin Liver Dis 2010; 14: 669-685. Epub 2010/11/09.
19. Isse K, Lesniak A, Grama K, et al. Pre-existing epithelial diversity in normal human livers: A tissue-tethered cytometric analysis in portal/periportal epithelial cells. Hepatology 2012; 57: 1632-1643. Epub 2012/11/15.
20. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
21. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31: 792-799. Epub 2000/03/08.
22. Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, Hart J, Hayry P, Hofmann WJ, Hubscher S, Kemnitz J, Koukoulis G, Lee RG, Lewin KJ, Ludwig J, Markin RS, Petrovic LM, Phillips MJ, Portmann B, Rakela J, Randhawa P, Reinholt FP, Reynes M, Robert M, Schlitt H, Solez K, Snover D, Taskinen E, Thung SN, Tillery GW, Wiesner RH, Wight DGD, Williams JW, Yamabe H., Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658-663. Epub 1997/03/01.
23. Stone JH, Zen Y, Deshpande V., IgG4-related disease. N Engl J Med 2012; 366: 539-551. Epub 2012/02/10.
24. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR., Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-D919. Epub 2010/11/11.
25. Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 2011; 46 (Suppl 1): 48-55. Epub 2010/09/24.
26. Suciu-Foca N, Harris PE, Cortesini R., Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol Rev 1998; 164: 241-246. Epub 1998/10/31.
27. Punnonen J, de Vries JE., IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J Immunol 1994; 152: 1094-1102. Epub 1994/02/01.
28. Satoguina JS, Adjobimey T, Arndts K, et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 2008; 38: 3101-3113. Epub 2008/10/17.
29. Ohta N, Makihara S, Okano M, et al. Roles of IL-17, Th1, and Tc1 cells in patients with IgG4-related sclerosing sialadenitis. Laryngoscope 2012; 122: 2169-2174. Epub 2012/07/13.
30. van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317: 1554-1557. Epub 2007/09/18.
31. Aalberse RC, Stapel SO, Schuurman J, Rispens T., Immunoglobulin G4: An odd antibody. Clin Exp Allergy 2009; 39: 469-477. Epub 2009/02/19.
32. Schuurman J, Van Ree R, Perdok GJ, Van Doorn HR, Tan KY, Aalberse RC., Normal human immunoglobulin G4 is bispecific: It has two different antigen-combining sites. Immunology 1999; 97: 693-698. Epub 1999/08/24.
33. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254.
34. Aini W, Miyagawa-Hayashino A, Tsuruyama T, et al. Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts. Transpl Int 2012; 25: 956-966. Epub 2012/07/11.
35. Hoare M, Gelson WT, Das A, et al. CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection. J Hepatol 2010; 53: 252-260. Epub 2010/05/14.
36. Gelson W, Hoare M, Vowler S, et al. Features of immune senescence in liver transplant recipients with established grafts. Liver Transpl 2010; 16: 577-587. Epub 2010/05/05.
37. Bonafe M, Olivieri F, Cavallone L, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31: 2357-2361.
38. Afshan G, Afzal N, Qureshi S., CD4+ CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clin Lab 2012; 58: 567-571. Epub 2012/07/13.
39. Listi F, Candore G, Modica MA, et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci 2006; 1089: 487-495. Epub 2007/01/31.
40. Gregg R, Smith CM, Clark FJ, et al. The number of human peripheral blood CD4+ CD25 high regulatory T cells increases with age. Clin Exp Immunol 2005; 140: 540-546. Epub 2005/06/04.
41. Yuasa T, Tsuji H, Kimura S, et al. Human leukocyte antigens in Japanese patients with biliary atresia: Retrospective analysis of patients who underwent living donor liver transplantation. Hum Immunol 2005; 66: 295-300. Epub 2005/03/24.
42. Haga H, Miyagawa-Hayashino A, Taira K, et al. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res 2007; 37 (Suppl 3): S463-S469. Epub 2007/10/13.
43. Schmidt H, Williamson D, Ashley-Koch A., HLA-DR15 haplotype and multiple sclerosis: A HuGE review. Am J Epidemiol 2007; 165: 1097-1109. Epub 2007/03/03.
44. Grimaldi LMMD, Reggio A, Raffaele R., IgG1,3 and 4 oligoclonal bands in multiple sclerosis and other neurological diseases. Ital J Neurol Sci 1986; 5: 507-513.
45. Pons JA, Revilla-Nuin B, Baroja-Mazo A, et al. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008; 86: 1370-1378. Epub 2008/11/27.
46. Li Y, Zhao X, Cheng D, et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008; 86: 1837-1843. Epub 2008/12/24.
47. Tisone G, Orlando G, Cardillo A, et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol 2006; 44: 702-709. Epub 2006/02/14.
48. Chang SY, Keogh K, Lewis JE, Ryu JH., Yi ES., Increased IgG4-positive plasma cells in granulomatosis with polyangiitis: A diagnostic pitfall of IgG4-related disease. Int J Rheumatol 2012; 2012: 1-6. Epub 2012/05/12.
49. Culver EL, Bateman AC., IgG4-related disease: Can non-classical histopathological features or the examination of clinically uninvolved tissues be helpful in the diagnosis ? J Clin Pathol 2012; 65: 963-969. Epub 2012/06/12.
50. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181-1192. Epub 2012/05/19.
51. de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, et al. IgG4+ clones identified by next-generation sequencing dominate the B-cell receptor repertoire in IgG4-associated cholangitis. Hepatology 2013; 57: 2390-2398. Epub 2013/01/10.
52. Adeyi O, Alexander G, Baiocchi L, et al. Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (OT). Liver Transpl 2012; 18: 1154-1170. Epub 2012/05/31.